Navigation Links
Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
Date:9/3/2013

mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  • For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

  • COMPLIANCE PROCEDURE

    Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

    NOT FINANCIAL ADVICE

    Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

    NO WARRANTY OR LIABILITY ASSUMED

    Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for
    '/>"/>

    SOURCE Analysts' Corner
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
    2. Magellan Diagnostics Receives FDA Clearance for LeadCare Ultra Bench-top Clinical Lead Analyzer
    3. Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer
    4. Selexys Pharmaceuticals Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients with Pain Crises
    5. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
    6. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
    7. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
    8. MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
    9. Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update
    10. Sanarias Malaria Vaccine Yields Unprecedented Protection In Phase 1 Clinical Trial
    11. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... GARDENS, Fla. , Jan. 15, 2014  In an unprecedented effort ... and TB in ambulances and other transport vehicles, an advanced and ... by rescue personnel for the first time. In ... contact with these deadly pathogens, West Palm Beach ...
    (Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
    (Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
    Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
    ... physicians in achieving better outcomes for AF, ... venous thromboembolism patients, INDIANAPOLIS, March 19 ... equipment and supplies for all long-term,warfarin users who monitor their own ... System for Patient Self-Testing. This,expansion opens the door to increased patient ...
    ... (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced ... patients with Type 1 diabetes,in a Phase 2 ... TPM/Insulin. The lead clinical investigators of the trial ... Royal Brisbane and,Women,s Hospital, and William Hsu, who ...
    Cached Medicine Technology:Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home 2Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home 3Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home 4Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes 2Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes 3
    (Date:4/22/2014)... April 22, 2014: The Association for Molecular Pathology ... Journal of Molecular Diagnostics on recommendations for ... and master,s levels of education. The report was ... Task Force of the AMP Training and Education ... need of educating future medical laboratory scientists appropriately ...
    (Date:4/22/2014)... advances and emerging therapies in heart failure will be ... of the Heart Failure Association (HFA) of the European ... news on acute heart failure during the first World ... the main congress. , The event will be held ... International Conference Centre (MAICC). The full scientific programme is ...
    (Date:4/22/2014)... demonstrated the first size-based form of chromatography that ... living cells. This unique physical approach to probing ... whether a cell lives or dies, remains normal ... conventional microscopy. , "We,ve developed membrane-embedded nanodot array ... probe and manipulate membrane assemblies, including signaling clusters, ...
    (Date:4/22/2014)... mothers are exposed to trauma, illness, alcohol or other ... trigger in brain cells that can go awry and ... some forms of autism. , Until now, it has ... cells of a developing brain. Past studies have shown ... or drug abuse or she experiences some trauma or ...
    (Date:4/22/2014)... In enemy territory, activate your cloaking device. And real-world ... the immune system. Now scientists at Harvard,s Wyss Institute ... to build the first DNA nanodevices that survive the ... way for smart DNA nanorobots that could use logic ... can today; target drugs to tumors, or even manufacture ...
    Breaking Medicine News(10 mins):Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:Life stressors trigger neurological disorders, researchers find 2Health News:Cloaked DNA nanodevices survive pilot mission 2Health News:Cloaked DNA nanodevices survive pilot mission 3
    ... 230th national meeting of the American Chemical Society in Washington ... biological agents through a sealed envelope and detect tumors without ... a wide variety of // applications and are based on ... by frequencies from 0.1 to 10 THz, just between infrared ...
    ... Scientists have discovered a naturally occurring hormone that can extend the ... gene for klotho began showing signs of premature aging around 3 ... months when compared to an average life span of 2 years. ... ,The hormone is produced in the brain and kidney in ...
    ... of Naturopathic Medicine, Toronto, had said in a ... the American Association of Naturopathic Physicians (AANP), that ... disorder., ,While many individuals are treated for ... in North America) with benzodiazepines or selective serotonin ...
    ... research report published in the latest edition of The ... treating adults with malaria than the common drug quinine., ... treatment // of severe malaria throughout Africa, South America, ... of the drug in maximum doses mortality from severe ...
    ... abuse has become a common problem among children and adolescents. ... on drugs, are more interested in dragging them for treatment. ... focus, which is given to identify the victim’s feelings of ... implications on the treatment outcomes., ,Shame is the tendency ...
    ... 26 . Japanese encephalitis deaths continue to rise in Uttar ... less than a month. //, ,Dr.T.N.Dhole from Microbiology Department ... blamed "official apathy" for the unabated spread of the ... for nearly three decades., ,Encephalitis is a mosquito borne ...
    Cached Medicine News:Health News:New Treatment For Anxiety Disorders 2Health News:Effective Treatment Of Drug Abuse Dependent On Feelings Of Shame Or Guilt 2Health News:Encephalitis Deaths Cross 220 in Uttar Pradesh 2
    Lacrimal cannula blunt tip with 0.3 mm side port, straight....
    McIntyre lacrimal cannula, dual 0.3 mm side ports, straight....
    Solo-care is a multi-purpose solution for cleaning, rinsing, disinfection and storing soft contact lenses....
    Graether Collar Button micro iris retractor....
    Medicine Products: